PRKAA2 and neoplasm: Overall we propose that, when loss of AMPK occurs prior to initiation of tumorigenesis in vivo, this would remove the restraints on the mTORC1 pathway and unleash other biosynthesis processes and the cell cycle, thus transforming the cells into a metabolic and proliferative state that is primed for tumour formation.